Clinical Trial Update: Pilot Study of Oligonol Supplementation to Promote Cardiovascular Health [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating Oligonol supplementation for cardiovascular health has completed. The trial was sponsored by the University of California, Davis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Oligonol

Snippet

Sponsor: University of California, Davis | Conditions: Cardiovascular Health | Phase 1 | Status: COMPLETED